Gene Editing Technology

Cibus Reports Q1 2025 Results & Expands Gene Editing Pipeline

Cibus reported a net loss of $49.4M for Q1 2025, mainly due to a $21M goodwill impairment, they also reported updates in regulatory decisions.

Read More

genXtraits & Solis Agrosciences Partner to Accelerate Crop Development

genXtraits partners with Solis Agrosciences to create & commercialize novel crop varieties or license them to seed companies.

Read More